Ribeiro RM - Search Results

1

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.

Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS; ACTIV-2/A5401 Study Team; Hughes MD, Smith DM. Chew KW, et al. Among authors: ribeiro rm. Nat Commun. 2022 Aug 22;13(1):4931. doi: 10.1038/s41467-022-32551-2. Nat Commun. 2022. PMID: 35995785 Free PMC article. Clinical Trial.

2

Modeling deuterated glucose labeling of T-lymphocytes.

Ribeiro RM, Mohri H, Ho DD, Perelson AS. Ribeiro RM, et al. Bull Math Biol. 2002 Mar;64(2):385-405. doi: 10.1006/bulm.2001.0282. Bull Math Biol. 2002. PMID: 11926122

3

Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase.

Ribeiro RM, Perelson AS. Ribeiro RM, et al. J Hepatol. 2002 Aug;37(2):277-9. doi: 10.1016/s0168-8278(02)00210-6. J Hepatol. 2002. PMID: 12127436 Review. No abstract available.

4

Dynamics of hepatitis B virus infection.

Ribeiro RM, Lo A, Perelson AS. Ribeiro RM, et al. Microbes Infect. 2002 Jul;4(8):829-35. doi: 10.1016/s1286-4579(02)01603-9. Microbes Infect. 2002. PMID: 12270730 Free article. Review.

5

In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?

Ribeiro RM, Mohri H, Ho DD, Perelson AS. Ribeiro RM, et al. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15572-7. doi: 10.1073/pnas.242358099. Epub 2002 Nov 14. Proc Natl Acad Sci U S A. 2002. PMID: 12434018 Free PMC article.

6

Mathematical modeling of viral kinetics: a tool to understand and optimize therapy.

Layden TJ, Layden JE, Ribeiro RM, Perelson AS. Layden TJ, et al. Among authors: ribeiro rm. Clin Liver Dis. 2003 Feb;7(1):163-78. doi: 10.1016/s1089-3261(02)00063-6. Clin Liver Dis. 2003. PMID: 12691465 Review.

7

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin.

Layden-Almer JE, Ribeiro RM, Wiley T, Perelson AS, Layden TJ. Layden-Almer JE, et al. Among authors: ribeiro rm. Hepatology. 2003 Jun;37(6):1343-50. doi: 10.1053/jhep.2003.50217. Hepatology. 2003. PMID: 12774013

8

Dynamics of alanine aminotransferase during hepatitis C virus treatment.

Ribeiro RM, Layden-Almer J, Powers KA, Layden TJ, Perelson AS. Ribeiro RM, et al. Hepatology. 2003 Aug;38(2):509-17. doi: 10.1053/jhep.2003.50344. Hepatology. 2003. PMID: 12883496

9

Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b.

Powers KA, Dixit NM, Ribeiro RM, Golia P, Talal AH, Perelson AS. Powers KA, et al. Among authors: ribeiro rm. Semin Liver Dis. 2003;23 Suppl 1:13-8. doi: 10.1055/s-2003-41630. Semin Liver Dis. 2003. PMID: 12934163 Clinical Trial.

10

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.

Torriani FJ, Ribeiro RM, Gilbert TL, Schrenk UM, Clauson M, Pacheco DM, Perelson AS. Torriani FJ, et al. Among authors: ribeiro rm. J Infect Dis. 2003 Nov 15;188(10):1498-507. doi: 10.1086/379255. Epub 2003 Nov 13. J Infect Dis. 2003. PMID: 14624375 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters